[{"address1": "1489 W. Warm Springs Road", "address2": "Suite 110", "city": "Henderson", "state": "NV", "zip": "89014", "country": "United States", "phone": "702 825 9872", "website": "https://zurabio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Zura Bio Limited, a clinical-stage biotechnology company, develops medicines for immune and inflammatory disorders in the United States. The company develops Tibulizumab, an immunoglobulin G-single-chain variable fragment bispecific dual-antagonist antibody engineered by the fusion of ixekizumab and tabalumab that neutralizes interleukin (IL)-17A and B-cell activating factor, which is in Phase 2 clinical trial development. It is also developing Torudokimab (ZB-880), a monoclonal antibody that neutralizes IL-33 to prevent ST2-dependent and ST2-independent inflammation, which has completed Phase 1/2 clinical studies; and Crebankitug (ZB-168), a monoclonal antibody that binds and neutralizes the IL-7 receptor alpha chain that impact on diseases driven by IL-7 and thymic stromal lymphopoietin immune pathways, which has completed Phase 1/1b clinical studies. Zura Bio Limited was founded in 2022 and is headquartered in Henderson, Nevada.", "fullTimeEmployees": 30, "companyOfficers": [{"maxAge": 1, "name": "Mr. Eric  Hyllengren", "age": 49, "title": "Chief Financial Officer", "yearBorn": 1975, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Gary  Whale Ph.D.", "age": 50, "title": "Chief Technology Officer", "yearBorn": 1974, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Theresa  Lowry", "age": 50, "title": "Chief Human Resources Officer", "yearBorn": 1974, "exercisedValue": 0, "unexercisedValue": 0}], "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 3.43, "open": 3.33, "dayLow": 3.18, "dayHigh": 3.51, "regularMarketPreviousClose": 3.43, "regularMarketOpen": 3.33, "regularMarketDayLow": 3.18, "regularMarketDayHigh": 3.51, "payoutRatio": 0.0, "beta": 0.254, "forwardPE": -4.3378377, "volume": 1069355, "regularMarketVolume": 1069355, "averageVolume": 1592990, "averageVolume10days": 1304110, "averageDailyVolume10Day": 1304110, "bid": 2.48, "ask": 4.07, "bidSize": 2, "askSize": 2, "marketCap": 208707968, "fiftyTwoWeekLow": 0.97, "fiftyTwoWeekHigh": 4.98, "allTimeHigh": 37.55, "allTimeLow": 0.97, "fiftyDayAverage": 2.5366, "twoHundredDayAverage": 1.686635, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 67421968, "profitMargins": 0.0, "floatShares": 37881471, "sharesOutstanding": 65018058, "sharesShort": 2050530, "sharesShortPriorMonth": 425343, "sharesShortPreviousMonthDate": 1756425600, "dateShortInterest": 1759190400, "sharesPercentSharesOut": 0.0315, "heldPercentInsiders": 0.27749002, "heldPercentInstitutions": 0.51222, "shortRatio": 0.61, "shortPercentOfFloat": 0.0348, "impliedSharesOutstanding": 69474124, "bookValue": 2.029, "priceToBook": 1.5820601, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -65425000, "trailingEps": -0.74, "forwardEps": -0.74, "enterpriseToEbitda": -0.932, "52WeekChange": -0.33540374, "SandP52WeekChange": 0.13837254, "quoteType": "EQUITY", "currentPrice": 3.21, "targetHighPrice": 26.0, "targetLowPrice": 2.0, "targetMeanPrice": 13.33333, "targetMedianPrice": 13.0, "recommendationMean": 1.42857, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 6, "totalCash": 154490000, "totalCashPerShare": 2.376, "ebitda": -72339000, "totalDebt": 0, "quickRatio": 8.263, "currentRatio": 8.397, "returnOnAssets": -0.26046, "returnOnEquity": -0.43553, "freeCashflow": -24324376, "operatingCashflow": -43570000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "ZURA", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1760738969, "regularMarketTime": 1760731200, "exchange": "NCM", "messageBoardId": "finmb_1783060399", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -6.41399, "regularMarketPrice": 3.21, "postMarketChangePercent": 1.86916, "postMarketPrice": 3.27, "postMarketChange": 0.0599999, "regularMarketChange": -0.22, "regularMarketDayRange": "3.18 - 3.51", "fullExchangeName": "NasdaqCM", "shortName": "Zura Bio Limited", "longName": "Zura Bio Limited", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1679405400000, "averageDailyVolume3Month": 1592990, "fiftyTwoWeekLowChange": 2.24, "fiftyTwoWeekLowChangePercent": 2.3092782, "fiftyTwoWeekRange": "0.97 - 4.98", "fiftyTwoWeekHighChange": -1.77, "fiftyTwoWeekHighChangePercent": -0.3554217, "fiftyTwoWeekChangePercent": -33.540375, "earningsTimestamp": 1754971200, "earningsTimestampStart": 1762432200, "earningsTimestampEnd": 1762432200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.74, "epsForward": -0.74, "fiftyDayAverageChange": 0.6733999, "fiftyDayAverageChangePercent": 0.26547343, "twoHundredDayAverageChange": 1.523365, "twoHundredDayAverageChangePercent": 0.90319777, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2023-03-21", "averageAnalystRating": "1.4 - Strong Buy", "cryptoTradeable": false, "displayName": "Zura Bio", "trailingPegRatio": null, "__fetch_time": "2025-10-18"}]